FTC Finalizes Consent Order in Ascension Health-AmSurg Acquisition, Requires Divestitures

The Federal Trade Commission (FTC) has finalized a consent order regarding Ascension Health Alliance's proposed $3.9 billion acquisition of AmSurg LLC. To address concerns about reduced competition, the order requires Ascension to divest seven ambulatory surgery centers across five metropolitan areas: Nashville, Tennessee; Panama City, Florida; Tulsa, Oklahoma; Waco, Texas; and Wichita, Kansas.

Context

Ascension Health Alliance's acquisition of AmSurg LLC, valued at $3.9 billion, raised concerns about decreased competition in several metropolitan areas. The FTC's consent order is a response to these concerns, ensuring that the merger does not lead to higher prices or reduced access to healthcare services. The requirement to divest seven ambulatory surgery centers is a significant regulatory action aimed at preserving market dynamics.

Why it matters

The FTC's decision highlights the agency's commitment to maintaining competition in the healthcare sector. By requiring divestitures, the FTC aims to prevent potential monopolistic practices that could harm consumers. This case underscores the regulatory scrutiny surrounding large healthcare acquisitions, which can significantly impact local markets.

Implications

The divestitures mandated by the FTC could lead to increased competition in the affected markets, potentially benefiting consumers through lower prices and improved access to care. Healthcare providers in the regions may experience shifts in market dynamics as new operators enter the space. This case may also set a precedent for how similar acquisitions are handled in the future.

What to watch

In the near term, the implementation of the divestiture plan will be closely monitored to ensure compliance with the FTC's order. Stakeholders, including healthcare providers and patients, will be observing how the divestitures impact local healthcare services. Additionally, the FTC may face further scrutiny regarding its approach to future healthcare mergers.